OBJECTIVES: The serotonin 2A receptor gene (5-HT2A) is of great interest for research in neuropsychiatric disorders based on the observation that various neuroleptic agents and antidepressants bind with relatively high affinity at 5-HT2A receptors, and the fact that the receptor density in platelets tends to increase in depression. To test for the presence of association between 5-HT2A and bipolar disorder (BP), we studied a large number of triad families having probands affected with DSM-IV bipolar I (BPI), bipolar II (BPII) or schizoaffective disorder, bipolar type. METHODS: Two polymorphisms of 5-HT2A, 102T/C, and His452Tyr were analyzed in the 274 bipolar triad families. Both the transmission disequilibrium test (TDT) and haplotype TDT were performed on the genotype data. We also calculated the maternal transmission and paternal transmission for each allele and compared the mean ages of onset across probands grouped by genotype at each of the two markers. RESULTS: No significant transmission disequilibrium between the alleles of 5-HT2A and BP was found. Separate studies of the sub-phenotypes also failed to demonstrate significant association. However, we found a trend towards transmission disequilibrium with the haplotype 102C.His452 (p = 0.0504). This trend may become more significant with a larger sample size. SIGNIFICANCE: At present, results of this study suggest that the 5-HT2A is unlikely to play a major role in the genetic susceptibility to BP. Future studies will be directed towards increasing sample size, focusing on subtypes of BP or biochemical measures as phenotypes, and investigating other polymorphisms of 5-HT2A to provide more information at the DNA level.
OBJECTIVES: The serotonin 2A receptor gene (5-HT2A) is of great interest for research in neuropsychiatric disorders based on the observation that various neuroleptic agents and antidepressants bind with relatively high affinity at 5-HT2A receptors, and the fact that the receptor density in platelets tends to increase in depression. To test for the presence of association between 5-HT2A and bipolar disorder (BP), we studied a large number of triad families having probands affected with DSM-IV bipolar I (BPI), bipolar II (BPII) or schizoaffective disorder, bipolar type. METHODS: Two polymorphisms of 5-HT2A, 102T/C, and His452Tyr were analyzed in the 274 bipolar triad families. Both the transmission disequilibrium test (TDT) and haplotype TDT were performed on the genotype data. We also calculated the maternal transmission and paternal transmission for each allele and compared the mean ages of onset across probands grouped by genotype at each of the two markers. RESULTS: No significant transmission disequilibrium between the alleles of 5-HT2A and BP was found. Separate studies of the sub-phenotypes also failed to demonstrate significant association. However, we found a trend towards transmission disequilibrium with the haplotype 102C.His452 (p = 0.0504). This trend may become more significant with a larger sample size. SIGNIFICANCE: At present, results of this study suggest that the 5-HT2A is unlikely to play a major role in the genetic susceptibility to BP. Future studies will be directed towards increasing sample size, focusing on subtypes of BP or biochemical measures as phenotypes, and investigating other polymorphisms of 5-HT2A to provide more information at the DNA level.
Authors: T Emahazion; L Feuk; M Jobs; S L Sawyer; D Fredman; D St Clair; J A Prince; A J Brookes Journal: Trends Genet Date: 2001-07 Impact factor: 11.639
Authors: A Heiden; P Schüssler; U Itzlinger; F Leisch; J Scharfetter; C Gebhardt; K Fuchs; M Willeit; L Nilsson; E Miller-Reiter; T Stompe; K Meszaros; W Sieghart; K Hornik; S Kasper; H N Aschauer Journal: Neuropsychobiology Date: 2000 Impact factor: 2.328
Authors: P F Goyer; M S Berridge; E D Morris; W E Semple; B A Compton-Toth; S C Schulz; D F Wong; F Miraldi; H Y Meltzer Journal: J Nucl Med Date: 1996-07 Impact factor: 10.057
Authors: B Mahieu; D Souery; O Lipp; K Mendelbaum; G Verheyen; V De Maertelaer; C Van Broeckhoven; J Mendlewicz Journal: Psychiatry Res Date: 1997-05-05 Impact factor: 3.222
Authors: N Ozaki; N E Rosenthal; U Pesonen; J Lappalainen; S Feldman-Naim; P J Schwartz; E H Turner; D Goldman Journal: Biol Psychiatry Date: 1996-12-15 Impact factor: 13.382